Lista de obras - Xuping Xie - Dominio Público Uruguay

A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis

artículo científico publicado en 2017

A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients

artículo científico publicado en 2017

A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission

article

A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine

artículo científico publicado en 2017

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

artículo científico publicado en 2020

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

artículo científico publicado en 2020

A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models

artículo científico publicado en 2017

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

scientific article published on 15 October 2020

A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis

artículo científico publicado en 2011

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage

artículo científico publicado en 2017

A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity

artículo científico publicado en 2018

A translation inhibitor that suppresses dengue virus in vitro and in vivo

artículo científico publicado en 2011

An Infectious cDNA Clone of SARS-CoV-2

scientific article published on 09 April 2020

An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors

artículo científico publicado en 2016

An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction

artículo científico publicado en 2018

Anti-Zika virus RNAi in neural progenitor cells

artículo científico publicado en 2019

Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells

scholarly article by Daniel P Strange et al published 16 July 2019 in mBio

Biochemical and genetic characterization of dengue virus methyltransferase

artículo científico publicado en 2010

Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants

artículo científico publicado en 2018

Characterization of dengue virus NS4A and NS4B protein interaction

artículo científico publicado en 2015

Defining the risk of SARS-CoV-2 variants on immune protection

artículo científico publicado en 2022

Dengue NS2A Protein Orchestrates Virus Assembly

scientific article published on 17 October 2019

Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione Analogues as Potent NS4B Inhibitors for the Treatment of Dengue Virus Infection

scientific article published on 23 August 2019

Design, synthesis and biological evaluation of spiropyrazolopyridone derivatives as potent dengue virus inhibitors

scientific article published on 30 March 2020

Determinants of Dengue Virus NS4A Protein Oligomerization

artículo científico publicado en 2015

Dimerization of flavivirus NS4B protein

artículo científico publicado en 2014

Engineering SARS-CoV-2 using a reverse genetic system

artículo científico publicado en 2021

Envelope protein ubiquitination drives entry and pathogenesis of Zika virus

artículo científico publicado en 2020

Erratum for Chen et al., "Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate"

scientific article published on 02 April 2019

Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA

scholarly article by Ruben Soto-Acosta et al published 4 December 2018 in eLife

Functional Analysis of Glycosylation of Zika Virus Envelope Protein

artículo científico publicado en 2017

Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus

artículo científico publicado en 2014

Genetic and biochemical characterizations of Zika virus NS2A protein

scholarly article published by Jing Zou in 2019

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

artículo científico publicado en 2021

Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.

artículo científico publicado en 2013

Inhibition of dengue virus by targeting viral NS4B protein ⬇️

artículo científico publicado el 24 de agosto de 2011

Mapping the Interactions between the NS4B and NS3 proteins of dengue virus

artículo científico publicado en 2015

Maternal vaccination and protective immunity against Zika virus vertical transmission

scientific article published on 12 December 2019

Membrane Topology and Function of Dengue Virus NS2A Protein

artículo científico publicado en 2013

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

artículo científico publicado en 2021

Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling

artículo científico publicado en 2016

Potential Mechanisms for Enhanced Zika Epidemic and Disease

artículo científico publicado en 2018

RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation

artículo científico publicado en 2017

Rational Design of a Flavivirus Vaccine by Abolishing Viral RNA 2′- O Methylation ⬇️

artículo científico publicado el 13 de marzo de 2013

Repurposing an HIV Drug for Zika Virus Therapy

artículo científico publicado en 2019

Restriction of Zika Virus by Host Innate Immunity

artículo científico publicado en 2016

Reverse Genetics of Zika Virus

artículo científico publicado en 2017

Secondary structure and membrane topology of dengue virus NS4B N-terminal 125 amino acids

artículo científico publicado en 2015

Small Molecules and Antibodies for Zika Therapy

artículo científico publicado en 2017

Spike mutation D614G alters SARS-CoV-2 fitness

artículo científico publicado en 2020

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility

scientific article published on 10 September 2020

Targeting dengue virus NS4B protein for drug discovery

artículo científico

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization

artículo científico publicado en 2021

Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses

artículo científico publicado en 2020

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate

scholarly article by Qi Chen et al published 18 September 2018 in mBio

Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly

artículo científico publicado en 2014

U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication ⬇️

artículo científico publicado el 29 de noviembre de 2011

Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis

artículo científico publicado en 2017

Using a virion assembly-defective dengue virus as a vaccine approach

scholarly article by Chao Shan et al published 15 August 2018 in Journal of Virology

Using recombination-dependent lethal mutations to stabilize reporter flaviviruses for rapid serodiagnosis and drug discovery

artículo científico publicado en 2020

Zika Virus NS2A-Mediated Virion Assembly

artículo científico publicado en 2019

Zika Virus Replicons for Drug Discovery

artículo científico publicado en 2016

Zika Virus Vaccine: Progress and Challenges

scholarly article published by Chao Shan in 2018

Zika Virus: Diagnosis, Therapeutics, and Vaccine

artículo científico publicado en 2016

Zika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonuclease

artículo científico publicado en 2016

Lista de obras de Xuping Xie

A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis

A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients

A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission

A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage

A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity

A translation inhibitor that suppresses dengue virus in vitro and in vivo

An Infectious cDNA Clone of SARS-CoV-2

An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors

An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction

Anti-Zika virus RNAi in neural progenitor cells

Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells

Biochemical and genetic characterization of dengue virus methyltransferase

Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants

Characterization of dengue virus NS4A and NS4B protein interaction

Defining the risk of SARS-CoV-2 variants on immune protection

Dengue NS2A Protein Orchestrates Virus Assembly

Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione Analogues as Potent NS4B Inhibitors for the Treatment of Dengue Virus Infection

Design, synthesis and biological evaluation of spiropyrazolopyridone derivatives as potent dengue virus inhibitors

Determinants of Dengue Virus NS4A Protein Oligomerization

Dimerization of flavivirus NS4B protein

Engineering SARS-CoV-2 using a reverse genetic system

Envelope protein ubiquitination drives entry and pathogenesis of Zika virus

Erratum for Chen et al., "Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate"

Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA

Functional Analysis of Glycosylation of Zika Virus Envelope Protein

Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus

Genetic and biochemical characterizations of Zika virus NS2A protein

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.

Inhibition of dengue virus by targeting viral NS4B protein ⬇️

Mapping the Interactions between the NS4B and NS3 proteins of dengue virus

Maternal vaccination and protective immunity against Zika virus vertical transmission

Membrane Topology and Function of Dengue Virus NS2A Protein

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling

Potential Mechanisms for Enhanced Zika Epidemic and Disease

RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation

Rational Design of a Flavivirus Vaccine by Abolishing Viral RNA 2′- O Methylation ⬇️

Repurposing an HIV Drug for Zika Virus Therapy

Restriction of Zika Virus by Host Innate Immunity

Reverse Genetics of Zika Virus

Secondary structure and membrane topology of dengue virus NS4B N-terminal 125 amino acids

Small Molecules and Antibodies for Zika Therapy

Spike mutation D614G alters SARS-CoV-2 fitness

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility

Targeting dengue virus NS4B protein for drug discovery

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization

Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate

Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly

U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication ⬇️

Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis

Using a virion assembly-defective dengue virus as a vaccine approach

Using recombination-dependent lethal mutations to stabilize reporter flaviviruses for rapid serodiagnosis and drug discovery

Zika Virus NS2A-Mediated Virion Assembly

Zika Virus Replicons for Drug Discovery

Zika Virus Vaccine: Progress and Challenges

Zika Virus: Diagnosis, Therapeutics, and Vaccine

Zika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonuclease